A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants
Clinical trial NCT03536325 · COMPLETED
Trial details
- NCT number
- NCT03536325
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-31
- Primary completion
- 2018-10-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.